Last reviewed · How we verify
NCT05140005
GlowTest COVID-19 Antigen Home Test Kit QRI Use Study
NA trial testing GlowTest COVID-19 Antigen Home Test in Covid 19 in 33 participants. Completed in 17 December 2021.
14 December 2021
Quick facts
| Lead sponsor | Arion Bio |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 33 |
| Start date | 6 December 2021 |
| Primary completion | 14 December 2021 |
| Estimated completion | 17 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- GlowTest COVID-19 Antigen Home Test
Conditions studied
- Covid 19 — all drugs for Covid 19 →
Sponsor
Arion Bio — full company profile →
Who can join
2 and older, any sex, with Covid 19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to determine the usability of the GlowTest COVID-19 Antigen Home Test in a simulated home use environment. This is an open label study to evaluate the usability of the GlowTest COVID-19 Antigen Home Test using information from the Quick Reference Instructions and website.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05140005
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Arion Bio trials
Trials by the same sponsor.
- NCT05172154 — GlowTest COVID-19 Antigen Home Test Kit Usability Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05140005 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arion Bio
- Last refreshed: 20 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05140005.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing